Starting Mounjaro: What Happens in the First Weeks?

Why does Mounjaro start at 2.5 mg when the therapeutic doses go much higher?

The first pen you use contains 2.5 mg of tirzepatide per weekly dose. Its job is adjustment, not treatment. Because Mounjaro slows gastric emptying and acts on appetite-signalling pathways via two gut-hormone receptors (GIP and GLP-1), starting too high would almost certainly cause significant nausea and vomiting. The starter dose keeps those effects manageable while your digestive system acclimatises to a fundamentally different set of signals.

After four weeks at 2.5 mg, your prescriber will typically move you to 5 mg, and increases continue in roughly four-week steps from there, 7.5 mg, 10 mg, 12.5 mg, up to 15 mg if needed and tolerated. The pace is guided by how you respond, not by a fixed calendar. You can read through the broader clinical picture on our tirzepatide overview page, which covers how the mechanism works in more detail. What to expect at each point is also worth reading before you begin: our guide to preparing for your first pen covers practical steps that make those early weeks smoother.

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed 2,539 adults with obesity over 72 weeks; participants reaching 15 mg saw an average body-weight reduction of around 20–21%. That outcome is the product of the full titration schedule, not the starting dose alone.

What side effects are most likely in the first few weeks of starting tirzepatide?

A question our prescribers hear most weeks is some version of: "Is the nausea normal, or should I be worried?" For most people, yes, it is expected. The most common side effects when starting Mounjaro are gastrointestinal: nausea, loose stools or constipation, indigestion, and a noticeably reduced appetite. They tend to peak in the first one to two weeks after starting or after a dose increase, then ease as your body adapts.

Staying well hydrated matters more than usual during this period. Some people find small, protein-rich meals easier to tolerate than larger ones; our page on electrolytes and Mounjaro explains why fluid and mineral balance deserves attention, particularly if nausea is significant.

Rarer but more serious side effects require prompt medical attention: severe, persistent stomach pain that radiates to the back can be a sign of pancreatitis, and in January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines. Gallbladder symptoms and signs of a serious allergic reaction also warrant immediate care. You can report any suspected side effect via the MHRA Yellow Card scheme. The NHS tirzepatide medicines page lists both common and rare effects clearly.

Mounjaro is not recommended during pregnancy, while breastfeeding, or if you are actively trying to conceive. It is not licensed for anyone under 18. These are clinical lines, not administrative ones, your prescriber will go through them at consultation.

How do you actually use the pen, and what does the injection routine look like?

Mounjaro comes as a pre-filled KwikPen, each pen contains four weekly doses, and you inject once a week, on the same day each week where possible. Suitable injection sites are the abdomen, front of the thigh, or upper arm; rotating between sites reduces local skin reactions over time. The injection itself is subcutaneous, meaning just under the skin rather than into muscle.

The pen is stored in the fridge at 2–8°C. For the exact rules around how long it can sit at room temperature before use, always check the Patient Information Leaflet that comes with your treatment, that document is the clinical authority, and the window should not be assumed. Storage and travel questions come up often enough that our practical tips for starting Mounjaro page addresses them directly.

If you miss a dose within four days of when it was due, you can take it as soon as you remember and then return to your regular schedule. Beyond four days, skip it and wait for your next scheduled dose. Adjusting timing or switching injection days: speak to your prescriber or refer to the leaflet rather than guessing. For anyone who has been on Mounjaro before and is thinking about picking it up again, our guide to restarting Mounjaro covers the safe way to return to treatment after a break.

Is Mounjaro available privately, and how does a clinical assessment work?

Mounjaro is a prescription-only medicine. In the UK the only legal route to it is through a prescriber who has assessed your health and judged it clinically appropriate. On the NHS, access is phased and criteria are strict, currently limited to those with a BMI of 40 or above alongside multiple qualifying conditions. Private treatment through a regulated pharmacy is the alternative for people who meet the licensed eligibility criteria but do not qualify for, or do not want to wait for, an NHS pathway.

Licensed eligibility for private treatment is BMI 30 or above, or BMI 27 or above with at least one weight-related health condition, though BMI alone never guarantees approval. The prescriber considers the full picture. For an honest overview of what treatment involves and what our service includes, the Mounjaro treatment page is the right starting point, and our weight-loss overview sets it alongside other licensed options. Cost is a reasonable question too; rather than quoting per-pen figures here, the context around what private Mounjaro involves financially is covered there.

If you are ready to find out whether treatment is suitable for you, speak to our prescribers, the consultation is free, reviewed the same day by a named GPhC-registered Independent Prescriber, and carries no obligation.